Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

High-risk acute myeloid leukemia has been associated with a poor outcome. Hematopoietic stem cell transplantation (HSCT) represents the only curative option for eligible patients. Relapse after HSCT is a dramatic event with poor chances of survival. With the aim of reducing the rate of post-HSCT rel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Martina Canichella, Matteo Molica, Carla Mazzone, Paolo de Fabritiis
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Series:	Current Oncology
Subjects:	acute myeloid leukemia (AML) hematopoietic stem cell transplantation (HSCT) maintenance therapy post-HSCT in AML targeted drugs cellular therapy hypometylating agents
Online Access:	https://www.mdpi.com/1718-7729/31/10/451
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Meng Zhang, et al.
Published: (2025-01-01)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
by: Ranjit Kumar Sahoo, et al.
Published: (2013-01-01)

Results of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with t(8;21)(q22;q22)/RUNX1-RUNX1T1 and Additional Cytogenetic Abnormalities
by: TL Gindina, et al.
Published: (2016-04-01)

Development of multivalent CAR T cells as dual immunotherapy and conditioning agents
by: Quenton Rashawn Bubb, et al.
Published: (2025-03-01)

CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
by: Pilar Lloret-Madrid, et al.
Published: (2025-05-01)

Increased Co-Expression of PD-L1 and CTLA-4 Predicts Poor Overall Survival in Patients with Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Chen C, et al.
Published: (2025-01-01)

Chromosomal Anomalies in Acute Myeloid Leukemia: Cytogenetic Results of -417 Cases Froma Single Center
by: Nüket Yürür-Kutlay, et al.
Published: (2017-04-01)

Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of “Rete Ematologica Pugliese” (REP)
by: M. Dargenio, et al.
Published: (2025-01-01)

Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy
by: Rafael Madero‐Marroquin, et al.
Published: (2025-06-01)

Genetic Mutations in Acute Myeloid Leukemia
by: OV Blau
Published: (2016-07-01)

Relapse-specific genetic patterns in the exomic mutational landscape in acute myeloid leukemia
by: Wardah Qureshi, et al.
Published: (2025-03-01)

Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid Leukemia
by: Kendall Diebold, et al.
Published: (2025-06-01)

Therapeutic Implications of Menin Inhibitors in the Treatment of Acute Leukemia: A Critical Review
by: Martina Canichella, et al.
Published: (2025-07-01)

Older Jehovah’s Witnesses with Acute Myeloid Leukemia: Hypomethylating Agents and Venetoclax as a Transfusion-Sparing Approach
by: Aditi Sharma, et al.
Published: (2025-06-01)

Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
by: Bhavana Bhatnagar, et al.
Published: (2025-04-01)

Congenital Acute Myeloid Leukemia (AML): A Case Report
by: Alsharidah S, et al.
Published: (2025-05-01)

AXL in myeloid malignancies – an elusive target?
by: Pia Aehnlich, et al.
Published: (2024-12-01)

Clinical and genetic characteristics of acute myeloid leukemia with t(8;21) in children and results of therapy according to protocol AML-MM-2000
by: I. I. Kalinina, et al.
Published: (2014-07-01)

Prognostic value of miR-106a and miR-20a in AML patients with chemotherapy or allo-HSCT treatment
by: Yue Liu, et al.
Published: (2025-12-01)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
by: Lucas Touzet, et al.
Published: (2019-03-01)

Tyrosine Kinase Inhibitor Post-Allogeneic Stem Cell Transplantation in Adult Philadelphia-Positive B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
by: Martina Canichella, et al.
Published: (2025-02-01)

FREQUENCY OF FMS-LIKE TYROSINE KINASE 3 KINASE DOMAIN POINT MUTATION (FLT3/TKD MUTATION) IN DIFFERENT AGE GROUPS OF ACUTE MYELOID LEUKEMIA PATIENTS.
by: Khaleeq unnisa, et al.
Published: (2014-08-01)

Impact of PD-1 and PD-L1 expression on treatment outcomes in newly diagnosed acute myeloid leukemia patients
by: Ugur Calis, et al.
Published: (2025-01-01)

Myeloid sarcoma: Experience from a tertiary care center in southern India – A series of eight unusual cases
by: Roobashri Murugan, et al.
Published: (2025-01-01)

Long-Term Donor Chimerism Monitoring for Relapse Risk Assessment After Pediatric Allo-HSCT
by: Prażmo A, et al.
Published: (2025-07-01)

Identifying acute myeloid leukemia subtypes based on pathway enrichment
by: Ling Zhong, et al.
Published: (2025-03-01)

Endothelial injury syndromes after hematopoietic stem cell transplantation: analyzing clinical case
by: Y. V. Skvortsova, et al.
Published: (2022-11-01)

Learning the therapeutic targets of acute myeloid leukemia through multiscale human interactome network and community analysis
by: Suruthy Sivanathan, et al.
Published: (2025-05-01)

Efficacy and safety of blinatumomab for the treatment of patients relapsing after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis
by: Huai-Peng Guo, et al.
Published: (2024-12-01)

The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia
by: Daniela Magliulo, et al.
Published: (2023-10-01)

FGFC1 overcomes Ara-C resistance in acute myeloid leukemia by inducing apoptosis and pyroptosis
by: Xiaohui Hu, et al.
Published: (2025-08-01)

Real-world efficacy and safety of letermovir versus ganciclovir prophylaxis in adolescent patients undergoing allogenic hematopoietic stem cell transplantation: a single center observational study
by: Ziwei Xu, et al.
Published: (2025-06-01)

Interpreting immune evasion: a novel assay for HLA loss detection
by: Linnéa Pettersson, et al.
Published: (2025-07-01)

Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
by: Joaquín Jerez, et al.
Published: (2025-06-01)

The Clinical Safety and Efficacy of Cytarabine and Daunorubicin Liposome (CPX‐351) in Acute Myeloid Leukemia Patients: A Systematic Review
by: Abdulwahab M. Alzahrani, et al.
Published: (2025-05-01)

CEBPA mutation in acute myeloid leukemia: prognostic impact of bZIP domain mutation
by: Roy Raj, et al.
Published: (2024-10-01)

Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients
by: MV Solov’ev, et al.
Published: (2018-10-01)

FLAG with Bortezomib in Children and Adolescents with Relapsed/Refractory Acute Myeloid Leukemia in a Resource-Limited Setting: A Single-Center Experience from India
by: Dipesh Dave, et al.

An interesting case of chronic myeloid leukemia with twists and turns
by: Thulasi Raman Ramalingam, et al.
Published: (2024-12-01)

Total body irradiation versus chemotherapy myeloablative conditioning in B-cell acute lymphoblastic leukaemia patients with first complete remission
by: Mengnan Lv, et al.
Published: (2025-03-01)